Inmedix believes that examining a disease process based on a narrow point of view is flawed. Certainly, diseases have causes and patients respond for discrete reasons. Yet, such constructs do not usually work well to help all of the patients all of the time.
Most research has focused on identifying the best treatment for each individual patient, i.e. classic, personalized medicine. Alternatively, Inmedix searched for co-factors able to independently intensify disease activity.
In medicine at large, two examples include how diet affects insulin performance for patients with diabetes and how sodium (salt) intake affects high blood pressure. Both co-factors can significantly influence the therapies patients use to treatment of diabetes and high blood pressure, respectively.
For decades, patients have complained that stress adversely affects rheumatoid arthritis and other autoimmune diseases. Inmedix has hypothesized that stress, managed within the brain by the autonomic nervous system (ANS), drives immune activity to excess to thereby, limit successful treatment outcomes.
We call it Immuno-autonomics.